Get started
Author

Yasuhide Motoyoshi

Different mechanisms for anti-tumor effects of low- and high-dose cyclophosphamide
2006 · Yasuhide Motoyoshi, Kazuhisa Kaminoda, et al. · Oncology Reports · 161
PDF
Association Between Liver Fibrosis and Insulin Sensitivity in Chronic Hepatitis C Patients
2006 · Naota Taura, Tatsuki Ichikawa, et al. · The American Journal of Gastroenterology · 91
Alpha-fetoprotein above normal levels as a risk factor for the development of hepatocellular carcinoma in patients infected with hepatitis C virus
2010 · Masakuni Tateyama, Hiroshi Yatsuhashi, et al. · Journal of Gastroenterology · 86
Abrogation of constitutive STAT3 activity sensitizes human hepatoma cells to TRAIL-mediated apoptosis
2007 · Mariko Kusaba, Kazuhiko Nakao, et al. · Journal of Hepatology · 65
Response to Lenvatinib Is Associated with Optimal RelativeDose Intensity in Hepatocellular Carcinoma: Experience in Clinical Settings
2019 · Ryu Sasaki, Masanori Fukushima, et al. · Cancers · 54
PDF
Carotid Intima-media Thickness and Small Dense Low-density Lipoprotein Cholesterol Increase after One Year of Treatment with Direct-acting Antivirals in Patients with Hepatitis C Virus Infection
2019 · Tatsuki Ichikawa, Hisamitsu Miyaaki, et al. · Internal Medicine · 42
PDF
DHMEQ, a novel NF-kB inhibitor, induces apoptosis and cell-cycle arrest in human hepatoma cells
2006 · Daisuke Nishimura, Hiroki Ishikawa, et al. · International Journal of Oncology · 39
PDF
Aging of patients with hepatitis C virus-associated hepatocellular carcinoma: Long-term trends in Japan
2006 · Naota Taura, Keisuke Hamasaki, et al. · Oncology Reports · 34
PDF
Two cases of non‐alcoholic steatohepatitis with development of hepatocellular carcinoma without cirrhosis
2006 · Tatsuki Ichikawa, Kenji Yanagi, et al. · Journal of Gastroenterology and Hepatology · 31
Hepatitis C virus‐related symptoms, but not quality of life, were improved by treatment with direct‐acting antivirals
2017 · Tatsuki Ichikawa, Hisamitsu Miyaaki, et al. · Hepatology Research · 23
PDF
Indices calculated by serum creatinine and cystatin C as predictors of liver damage, muscle strength and sarcopenia in liver disease
2020 · Tatsuki Ichikawa, Hisamitsu Miyaaki, et al. · Biomedical Reports · 21
PDF
Direct-acting Antivirals Improved the Quality of Life, Ameliorated Disease-related Symptoms, and Augmented Muscle Volume Three Years Later in Patients with Hepatitis C Virus
2020 · Tatsuki Ichikawa, Hisamitsu Miyaaki, et al. · Internal Medicine · 19
PDF
Changes in serum LDL, PCSK9 and microRNA‑122 in patients with chronic HCV infection receiving Daclatasvir/Asunaprevir
2019 · Tatsuki Ichikawa, Hisamitsu Miyaaki, et al. · Biomedical Reports · 19
PDF
Prediction of early HBeAg seroconversion by decreased titers of HBeAg in the serum combined with increased grades of lobular inflammation in the liver
2012 · Sung Kwan Bae, Hiroshi Yatsuhashi, et al. · Medical Science Monitor · 18
PDF
Relationship between Regulatory T Cells and the Combination of Pegylated Interferon and Ribavirin for the Treatment of Chronic Hepatitis Type C
2010 · Motohisa Akiyama, Tatuki Ichikawa, et al. · Intervirology · 17
Clinical benefits of hepatocellular carcinoma surveillance: A single-center, hospital-based study
2005 · Naota Taura, Keisuke Hamasaki, et al. · Oncology Reports · 15
A genome-wide association study identified PTPN2 as a population-specific susceptibility gene locus for primary biliary cholangitis
2024 · Yuki Hitomi, Kazuko Ueno, et al. · Hepatology · 14
Calculated body muscle mass as a useful screening marker for low skeletal muscle mass and sarcopenia in chronic liver disease
2020 · Tatsuki Ichikawa, Hisamitsu Miyaaki, et al. · Hepatology Research · 14
Cerebral lipiodol embolism related to a vascular lake during chemoembolization in hepatocellular carcinoma: A case report and review of the literature
2018 · Hideki Ishimaru, Minoru Morikawa, et al. · World Journal of Gastroenterology · 12
PDF
Distinct responses of two hepatocellular carcinoma cell lines of a similar origin to immunotherapies targeting regulatory or effector T cells
2007 · Yuji Nagayama, Wataru Hase, et al. · Oncology Reports · 10
PDF
Comparison of calculated body muscle mass and SARC‑F as methods of screening for sarcopenia in patients with chronic liver disease
2021 · Tatsuki Ichikawa, Hisamitsu Miyaaki, et al. · Biomedical Reports · 9
PDF
Sequential occurrence of acute hepatitis B among members of a high school S umo wrestling club
2013 · Sung Kwan Bae, Hiroshi Yatsuhashi, et al. · Hepatology Research · 8
Liver Function in Older Patients With Unresectable Hepatocellular Carcinoma After Administration of Lenvatinib
2021 · RYU SASAKI, MASANORI FUKUSHIMA, et al. · Anticancer Research · 7
PDF
Zinc supplementation with polaprezinc was associated with improvements in albumin, prothrombin time activity, and hemoglobin in chronic liver disease
2023 · Seigo Abiru, Yuki Kugiyama, et al. · Journal of Clinical Biochemistry and Nutrition · 4
PDF
Temporal trends and regional variations in hepatocellular carcinoma etiology: a multinational study across Asia
2026 · Yasuto Takeuchi, Ryosuke Tateishi, et al. · Hepatology International · 3
PDF
Works count: 49
Citation count: 827
H-index: 15
I10-index: 20
Year
Topic
Type